Search Results - "DeLanney, L.E."

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Dopamine uptake blockers protect against the dopamine depleting effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse striatum by Ricaurte, G A, Langston, J W, DeLanney, L E, Irwin, I, Brooks, J D

    Published in Neuroscience letters (06-09-1985)
    “…1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), a recently described neurotoxin, produces a marked dopamine (DA) depletion in the mouse striatum. In this…”
    Get more information
    Journal Article
  2. 2

    Novel observations with FDOPA-PET imaging after early nigrostriatal damage by Yee, R.E., Irwin, I., Milonas, C., Stout, D.B., Huang, S-C., Shoghi-Jadid, K., Satyamurthy, N., Delanney, L.E., Togasaki, D.M., Farahani, K.F., Delfani, K., Janson, A.M., Phelps, M.E., Langston, J.W., Barrio, J.R.

    Published in Movement disorders (01-09-2001)
    “…Striatal 6‐[18F]fluoro‐L‐DOPA (FDOPA) kinetic rate constants were measured by positron emission tomography (PET) in…”
    Get full text
    Journal Article Conference Proceeding
  3. 3

    Toxic effects of MDMA on central serotonergic neurons in the primate: importance of route and frequency of drug administration by Ricaurte, G A, DeLanney, L E, Irwin, I, Langston, J W

    Published in Brain research (12-04-1988)
    “…This study compared the toxic effects of oral versus subcutaneous and single versus multiple doses of 3,4-methylenedioxymethamphetamine (MDMA) on central…”
    Get more information
    Journal Article
  4. 4

    Nigrostriatal Reduction of Aromatic L‐Amino Acid Decarboxylase Activity in MPTP‐Treated Squirrel Monkeys: In Vivo and In Vitro Investigations by Yee, R.E., Huang, S.‐C., Stout, D.B., Irwin, I., Shoghi‐Jadid, K., Togaski, D.M., DeLanney, L.E., Langston, J.W., Satyamurthy, N., Farahani, K.F., Phelps, M.E., Barrio, J.R.

    Published in Journal of neurochemistry (01-03-2000)
    “…Aromatic L‐amino acid decarboxylase (AAAD) activity was examined in vivo with positron emission tomography (PET) using 6‐[18F]fluoro‐L‐DOPA (FDOPA) in squirrel…”
    Get full text
    Journal Article
  5. 5

    Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra by Ricaurte, G A, Irwin, I, Forno, L S, DeLanney, L E, Langston, E, Langston, J W

    Published in Brain research (10-02-1987)
    “…This study assessed the influence of aging on substantia nigra degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). Extensive neuronal…”
    Get more information
    Journal Article
  6. 6

    5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates by Ricaurte, G A, DeLanney, L E, Wiener, S G, Irwin, I, Langston, J W

    Published in Brain research (06-12-1988)
    “…This study examined whether 5-hydroxyindoleacetic acid (5-HIAA) in cerebrospinal fluid (CSF) could be used to detect serotonergic damage induced by…”
    Get more information
    Journal Article
  7. 7

    Older dopaminergic neurons do not recover from the effects of MPTP by Ricaurte, G A, DeLanney, L E, Irwin, I, Langston, J W

    Published in Neuropharmacology (01-01-1987)
    “…Recent studies have shown that dopaminergic neurons in young mature mice recover fully from toxic injury induced by MPTP. The aim of the present study was to…”
    Get more information
    Journal Article
  8. 8

    3,4-Methylenedioxyethylamphetamine (MDE), a novel analogue of MDMA, produces long-lasting depletion of serotonin in the rat brain by Ricaurte, G A, Finnegan, K F, Nichols, D E, DeLanney, L E, Irwin, I, Langston, J W

    Published in European journal of pharmacology (04-06-1987)
    “…The present study was carried out to asses possible toxic effects of 3,4-methylenedioxyethylamphetamine (MDE) on serotonergic, dopaminergic or noradrenergic…”
    Get more information
    Journal Article
  9. 9

    Evaluation of the neurotoxic potential of N,N-dimethylamphetamine: an illicit analog of methamphetamine by Ricaurte, G A, DeLanney, L E, Irwin, I, Witkin, J M, Katz, J L, Langston, J W

    Published in Brain research (26-06-1989)
    “…The purpose of this study was to evaluate the neurotoxic potential of N,N-dimethylamphetamine (N,N-DMA), a controlled substance analog that has recently…”
    Get more information
    Journal Article
  10. 10

    The dopamine-depleting effect of 6-hydroxydopamine does not increase with aging by Ricaurte, G A, DeLanney, L E, Finnegan, K T, Irwin, I, Langston, J W

    Published in Brain research (12-01-1988)
    “…The dopamine-depleting effects of intracerebroventricularly administered 6-hydroxydopamine (6-OHDA) were studied in young mature (6-8 weeks), older (8-12…”
    Get more information
    Journal Article